阿莫西林克拉维酸钾胶囊治疗急慢性咽扁桃体炎的疗效

发布时间：2018-04-10 23:32

本文选题：急慢性咽扁桃体炎 + 阿莫西林克拉维酸钾胶囊　；参考：《中华医院感染学杂志》2014年24期

【摘要】：目的观察阿莫西林克拉维酸钾胶囊治疗急慢性咽扁桃体炎的临床疗效,以降低医疗成本。方法选取2011年6月-2013年6月收治的136例急慢性咽扁桃体炎患者按入院顺序随机分为观察组和对照组,各68例,两组患者入院确诊后给予对症支持治疗,观察组给予阿莫西林克拉维酸钾胶囊含服;对照组患者采用阿莫西林克拉维酸钾注射液静脉滴注;比较两组患者临床指标、治疗效果及不良反应,采用SPSS17.0进行统计分析。结果患者治疗总有效率观察组为92.65%、对照组为94.12%,两组患者疗效比较差异无统计学意义;两组患者不良反应发生率差异无统计学意义。结论阿莫西林克拉维酸钾胶囊治疗急慢性咽扁桃体炎疗效显著,不良反应轻微,尤其治疗患者的咽痛疗效更为显著。
[Abstract]:Objective to observe the clinical effect of amoxicillin clavulanate potassium capsule on acute and chronic pharyngeal tonsillitis.Methods from June 2011 to June 2013, 136 patients with acute and chronic pharyngeal tonsillitis were randomly divided into two groups: observation group (n = 68) and control group (n = 68).The observation group was given amoxicillin clavulanate potassium capsules and the control group was treated with amoxicillin clavulanate potassium injection intravenous drip. The clinical indexes, therapeutic effect and adverse reactions were compared between the two groups. SPSS17.0 was used for statistical analysis.Results the total effective rate of treatment was 92.65g in the observation group and 94.12g in the control group. There was no significant difference in the curative effect between the two groups, and there was no significant difference in the incidence of adverse reactions between the two groups.Conclusion amoxicillin clavulanate potassium capsule is effective in the treatment of acute and chronic pharyngeal tonsillitis with slight side effects, especially in patients with pharynx pain.
【作者单位】：铜仁市人民医院门诊部;
【基金】：贵州省科技厅科技基金资助项目(120127)
【分类号】：R766.1

【参考文献】